Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

High doses of minoxidil can harm marmoset hearts and kidneys, possibly affecting humans similarly.

Nanoparticles improve minoxidil skin permeation, but more research needed for effective hair growth.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Dog hair grows back in about 14 weeks after being clipped for surgery, and the season doesn't really affect this growth rate.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Filaggrin mutations are linked to atopic dermatitis and help explain how genetics and environment affect the disease.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Baricitinib is effective and safe for treating severe alopecia areata.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Entrepreneurial companies are key to advancing dermatology treatments and patient care.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

The document concluded that stem cells are crucial for skin repair, regeneration, and may help in developing advanced skin substitutes.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.